A detailed history of Nuveen Asset Management, LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 18,420 shares of NPCE stock, worth $264,327. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,420
Previous 18,420 -0.0%
Holding current value
$264,327
Previous $139,000 7.91%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$6.38 - $15.33 $117,519 - $282,378
18,420 New
18,420 $139,000
Q2 2022

Aug 15, 2022

SELL
$4.95 - $8.7 $88,357 - $155,295
-17,850 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$15.85 - $25.07 $108,445 - $171,528
6,842 Added 62.15%
17,850 $311,000
Q2 2021

Aug 16, 2021

BUY
$19.03 - $26.5 $209,482 - $291,712
11,008 New
11,008 $262,000

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $357M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.